Clinical Trial Update: A Real-World Study of Pegylated Interferon In Nucleoside-treated Patients With Chronic Hepatitis B [Phase 4]

View source ↗

Summary

This document reports a Phase 4 real-world study update evaluating pegylated interferon in nucleoside-treated patients with chronic hepatitis B, sponsored by To…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Tongji Hospital | Conditions: Chronic Hepatitis B | Phase 4 | Status: UNKNOWN